Earlogic Auditory Research Institute
Seoul, 121-270, South Korea
NCT Number: NCT01434446
In the late 1990s, researchers discovered that acoustic stimuli slow progressive sensorineural hearing loss and exposure to a moderately augmented acoustic environment can delay the loss of auditory function. In addition, prolonged exposure to an augmented acoustic environment could improve age-related auditory changes. These ameliorative effects were shown in several types of mouse strains, as long as the acoustic environment was provided prior to the occurrence of severe hearing loss.
In addition to delaying progressive hearing loss, acoustic stimuli could also protect hearing ability against damage by traumatic noise. In particular, a method called forward sound conditioning (i.e., prior exposure to moderate levels of sound) has been shown to reduce noise-induced hearing impairment in a number of mammalian species, including humans.
Interestingly, recent report has suggested that low-level sound conditioning also reduces free radical-induced damage to hair cells, increases antioxidant enzyme activity, and reduces Cox-2 expression in cochlea, and can enhance cochlear sensitivity. Specifically, increased cochlear sensitivity was observed when distortion product otoacoustic emissions (DPOAEs) and compound action potentials (CAPs) were measured.
In addition to forward sound conditioning, backward sound conditioning (i.e., the use of acoustic stimuli after exposure to a traumatic noise) has been shown to protect hearing ability against acoustic trauma and to prevent the cortical map reorganization induced by traumatic noise.
In this study, the investigators examine the effect of sound stimulation on hearing ability in human subjects.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Seoul, 121-270, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Listening to sound stimuli at the lowest audible level.
Time frame: 2~6 months
Pure-tone hearing thresholds of the baseline and the final point (after 2~6 months)will be compared.
Earlogic Korea, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023036
Cytomegalovirus Infection, Cytomegalovirus Infections
Bethesda, Maryland, United States
View Trial DetailsNCT02038972
Ear Diseases, Hearing Disorders
Orlando, Florida, United States
View Trial DetailsNCT05402969
Ear Diseases, Fibrosis
Montpellier, France
View Trial DetailsNCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial Details